Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Multiple sclerosis: Brain volume loss strengthens disease measure.
Patients' perspectives on quality of mental health care for people with MS.
Killer-Cell Immunoglobulin-Like Receptor Expression on Lymphocyte Subsets in Multiple Sclerosis Patients Treated with Interferon-β: Evaluation as Biomarkers for Clinical Response.
Interferon-γ Activates Nuclear Factor-κ B in Oligodendrocytes through a Process Mediated by the Unfolded Protein Response.
[The quality of nighttime sleep in patients with multiple sclerosis].
[Vitamin D and multiple sclerosis].
Aquaporin-4 Autoantibodies in Neuromyelitis Optica: AQP4 Isoform-Dependent Sensitivity and Specificity.
Short-term evolution of spinal cord damage in multiple sclerosis: a diffusion tensor MRI study.
Brain-derived neurotrophic factor and its clinical implications.
Danish translation and psychometric testing of the Rivermead Mobility Index.
Cladribine: mode of action and implications for treatment of multiple sclerosis.
High-mobility group box 1 up-regulates aquaporin 4 expression via microglia-astrocyte interaction.
Sox2 Sustains Recruitment of Oligodendrocyte Progenitor Cells following CNS Demyelination and Primes Them for Differentiation during Remyelination.
Transverse myelitis following combined spinal-epidural anesthesia.
Clinically isolated syndromes suggestive of multiple sclerosis: an optical coherence tomography study.
Human Mesenchymal Stem Cells Upregulate CD1dCD5(+) Regulatory B Cells in Experimental Autoimmune Encephalomyelitis.
The diadenosine homodinucleotide P18 improves in vitro myelination in experimental Charcot-Marie-Tooth type 1A.
Self-rating makes the difference: Identifying palliative care needs of patients feeling severely affected by multiple sclerosis.
Can the irradiated brain be salvaged by oligodendrocyte precursor transplantation?
T Cell Mediated Pathogenesis in EAE: Molecular Mechanisms.
Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation.
Recommendations for optimal ICD codes to study neurologic conditions: A systematic review.
[New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimode].
LIVER X RECEPTORS, NERVOUS SYSTEM AND LIPID METABOLISM.
Effects of vitamin D on immune disorders with special regard to asthma, COPD and autoimmune diseases: a short review.
Pages
« first
‹ previous
…
293
294
295
296
297
298
299
300
301
…
next ›
last »